|

Pertuzumab/Trastuzumab/Hyaluronidase-zzxf Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PHESGO

Pipeline

Phase 2: 1

Top Sponsors

  • Baylor Breast Care Center1

Indications

  • Estrogen Receptor-positive Breast Cancer1
  • Breast Cancer Stage III1
  • Breast Cancer Stage II1
  • Triple Negative Breast Neoplasms1
  • Triple Negative Breast Cancer1

Houston, Texas1 trial

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

Harris Health System - Smith Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.